Daniel Glenn Gibson

This inventor holds 32 USPTO granted patents and 13 published patent applications, plus 6 CIPO patents and 15 EPO patents, primarily in Nucleic Acid Synthesis. Top assignees: Synthetic Genomics, Inc., Codex Dna, Inc., Telesis Bio Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Glenn Gibson. Retrieved from https://idiyas.com/inventor/daniel-glenn-gibson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 (Patent Applications = 13)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 15 (Patent Applications = 12)

Average Co-Inventor Count = 3.5

ph-index = 7

Forward Citations = 368(Granted Patents)

Location History:

Mayfield Heights, OH (US) (2019)
Crofton, MD (US) (2010 - 2022)
Carlsbad, CA (US) (2017 - 2024)

Company Filing History:

14 out of 79

Synthetic Genomics, Inc.

Telesis Bio Inc. (Formerly Known as Codex Dna, Inc.)

Keene Building Products Co., Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Nucleic Acid Synthesis

Digital to Biological Converter

Synthetic Genomes

Polynucleotide Sequences

In Vitro Recombination

Error-Minimized Molecules

Genome Manipulation

Cloning Methods

Combinatorial Assembly

Recombinant Organisms

DNA Assembly

Tamper-Resistant Assembly

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12589396 - DIGITAL TO BIOLOGICAL CONVERTER (2026-03-31),

2. 12371724 - Methods for in vitro joining and combinatorial assembly of nucleic acid molecules (2025-07-29),

3. 12234450 - Generation of synthetic genomes (2025-02-25),

4. 12065684 - Demand synthesis of polynucleotide sequences (2024-08-20),

5. 12018316 - Methods for assembling nucleic acids (2024-06-25),

6. 11884916 - Materials and methods for the synthesis of error-minimized nucleic acid molecules (2024-01-30),

7. 11746321 - Methods of cloning nucleic acids or producing proteins in a low endotoxin organism (2023-09-05),

8. 11618029 - Digital to biological converter (2023-04-04),

9. 11542529 - In vitro recombination method (2023-01-03),

10. 11408020 - Methods for in vitro joining and combinatorial assembly of nucleic acid molecules (2022-08-09),

11. 11085037 - Generation of synthetic genomes (2021-08-10),

12. 11060137 - Methods for assembling DNA molecules (2021-07-13),

13. 11027282 - Digital to biological converter (2021-06-08),

14. 10968496 - Recombinant Vibrio natriegens organisms having a modified outer membrane (2021-04-06),

15. 10704041 - Materials and methods for the synthesis of error-minimized nucleic acid molecules (2020-07-07),

Title: The Innovative Mind of Daniel Glenn Gibson

Introduction

Daniel Glenn Gibson, based in Crofton, Maryland, is a prolific inventor known for his significant contributions to the field of synthetic biology. With an impressive portfolio of 28 patents, Gibson's work focuses primarily on the methods of synthesizing DNA molecules and improving the efficiency of oligonucleotide assembly.

Latest Patents

Gibson's latest patents reflect his innovative thinking around polynucleotide synthesis. One notable invention is the method for demand synthesis of polynucleotide sequences. This invention provides a novel approach to synthesizing DNA molecules with predetermined sequences through the annealing of long and short oligonucleotides to an anchor strand. Another groundbreaking patent he holds involves methods for assembling nucleic acids, which facilitate the creation of DNA molecules with high sequence fidelity by using DNA ligases in conjunction with a carefully curated library of oligonucleotides.

Career Highlights

Throughout his career, Gibson has worked with esteemed organizations such as Synthetic Genomics, Inc. and Codex DNA, Inc. His work in these companies has further solidified his reputation as a key figure in advancing genetic engineering and synthetic biology, particularly in methods to efficiently create complex DNA sequences that have applications in various biotechnological fields.

Collaborations

Daniel Gibson has collaborated with prominent figures in science, including Hamilton O. Smith and J. Craig Venter. These partnerships have enabled him to leverage collective expertise in pushing the boundaries of genetic research and innovation.

Conclusion

Daniel Glenn Gibson continues to influence the field of synthetic biology through his inventive spirit and extensive patent portfolio. His contributions not only pave the way for future innovations in DNA synthesis but also highlight the importance of collaboration and ingenuity in scientific advancements.

Profile summary based on public USPTO records.